Claudia Lanari
9PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 28, 2024
FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.María S Rodriguez, Yamil D Mahmoud, Silvia Vanzulli
|Oct 25, 2024
Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6.Florencia Cascardo, Micaela Vivanco, María Cecilia Perrone
|Nov 14, 2023
Steroid profile in patients with breast cancer and in mice treated with mifepristone.Andres Elía, Leo Saldain, Silvia Lovisi
|Oct 21, 2022
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.Andrés Elía, Leo Saldain, Silvia I Vanzulli
|Jan 03, 2022
New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.Cecilia Pérez Piñero, Sebastián Giulianelli, Caroline A Lamb
|Dec 22, 2021
Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.María Florencia Abascal, Andrés Elia, Michelle Alvarez
Pageof 2
Frequent Collaborators
4 joint publications
Caroline A Lamb
3 joint publications
Sebastián Giulianelli
2 joint publications
Cecilia Pérez Piñero
2 joint publications
Silvia Vanzulli
2 joint publications
Virginia Novaro
1 joint publications
Ramiro M Perrotta
1 joint publications
Andrés Elía
1 joint publications
Leo Saldain
1 joint publications
Luisa A Helguero
1 joint publications
Victoria Fabris
